Unknown cause of death or significant disease of unknown etiology in the medical history | |
Viral donor diseases: HIV (human immunodeficiency virus) infection, hepatitis B/C, HTLV I/II (human T-lymphotropic virus) or special risk factors for these infections | |
Bacterial donor diseases: syphilis or other chronic persistent bacterial infections: brucellosis, typhus, rickettsiosis, leprosy, relapsing fever, melioidosis, tularemia | |
Protozoonotic donor diseases: babesiosis, trypanosomiasis (e.g., Chagas disease), leishmaniasis | |
Active systemic infections: bacterial, viral, fungal, parasitic or of unknown cause | |
Fungal sepsis or sepsis with multi-resistant germs (a bacterial sepsis with the usual spectrum is not a contraindication) | |
Disorders of the central nervous system (CNS) of unclear cause: Alzheimer’s disease, Parkinson’s disease, unclear rapidly progressing dementia, multiple sclerosis, amyotrophic lateral sclerosis, retroviral CNS disease | |
Hematological neoplasias, leukemias, lymphomas | |
Ophthalmic donor diseases with visible changes in the cornea, condition after corneal surgery, local infection, tumors of the eye | |
Status after post-exposure vaccination against rabies within 12 months, status after live vaccines within 4 weeks | |
Risk of disease transmission through prions: patients after dura mater-, cornea-, sclera-, hetero- or xenotransplantation, recipients of pituitary hormones, diagnosed Creutzfeldt-Jacob disease in the donor or in the family history | |
Premortal use of substances that could have harmful effects on the recipient due to the transplant (e.g., poisons, heavy metals) | |
Donors with premortal plasma thinning of more than 50% due to previous transfusions (plasma dilution up to 22.5 ml per kg of body weight is acceptable) | |
Temporary exclusion: 2 years after healing of salmonellosis, Q-fever, tuberculosis, leptospirosis; 4 years after malaria cured; 4 weeks after measles, rubella, Varicella-zoster virus (VZV) or other serious viral diseases have healed | |
Risk of ZIKV (Zika virus) infection | |
Information about other unclear diseases; colonization or infection with Methicillin-resistant Staphylococcus aureus (MRSA)/ Extended spectrum beta-lactamases (ESBL)/ Vancomycin-resistant Staphylococcus aureus (VRSA) | |
Indications of incomplete or unreliable medical history, doubts as to the accuracy of the information | |
Additional information: natural death or confiscation by criminal police, diabetes mellitus, condition after chemotherapy and radiation therapy | |
Coronavirus disease 2019 since March 2020 |